NANOVIRICIDES, INC. NNVC Cash Flow

Nanoviricides, inc. (NNVC)

CashFlow / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
-1,927	-1,561	-	-	-2,230	-1,841	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-2,109	-2,796	-2,005	-	-3,138	-1,546	-3,061	-1,650	-4,991	-2,775	-1,306	-917	-251	-1,881	851	-7,000	1,323	-1,363	-6,561	-2,180	-3,682	-1,208	-1,803	-1,644	-2,031	-1,391	-1,139	-1,257	-2,546	-1,575	-1,097
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued for license
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Preferred shares issued for license
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Preferred shares issued as compensation
49	51	52	77	53	55	80	131	153	158	170	746	172	182	334	210	154	182	671	48	84	72	2,052	7	63	0	0	445	0	0	348	634	0	0	-1,418	1,364	53	0
Common shares issued as compensation and for services
38	38	42	115	38	86	86	103	38	38	131	120	38	38	202	63	38	41	163	39	38	38	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrants granted to Scientific Advisory Board
0	0	0	1	1	1	2	4	4	5	5	5	9	17	13	12	8	8	7	12	16	22	31	30	31	106	34	31	34	40	47	51	56	56	50	54	55	45
Common shares issued as compensation and for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	32	32	32	33	83	29	18	17	199	18	18	1,436	334	80	15
Common shares issued for debenture interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-665	0	0	-	-	-	-	-	-	-	-
Common Stock issued upon cashless exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock issued for interest on debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	0	0	-	-	-	-	-	-	-	-
Shares of common stock issued in connection with debenture offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued upon conversion of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued for services rendered
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	32	-	83	29	18	-	-	-	-	-	-	-	-
Common stock for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Preferred stock issued as compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	445	0	0	-	-	-	-	-	-	-	-
Stock-based compensation expense
0	0	0	0	0	11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0
Depreciation
172	172	172	172	171	171	170	168	166	166	165	163	162	163	162	163	163	161	140	51	51	51	51	45	53	52	52	52	52	52	52	48	57	52	-	-	-	-
Amortization
2	2	-	-	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization
-	-	-	-	-	-	-	2	2	2	-	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	6	-2	2	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52	53	51
Change in fair value of derivative liability
-147	421	-52	-65	122	175	604	284	1,100	564	20	255	1,407	13	1,457	-2,318	-85	1,487	2,065	3,054	391	3,017	-3,028	5,371	639	-4,425	-579	-443	19	-246	-241	-14	74	8	-3	10	-80	11
Amortization of debt discount convertible debentures
-	-	-	-	-	-	0	0	119	239	223	297	423	403	380	362	349	333	314	297	289	273	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Amortization of debt discount convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	143	140	135	0	0	0	0	-	-	-	-	-	-	-	-
Discount on convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Beneficial conversion feature of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	-	-	-	-
Changes in operating assets and liabilities:
Non cash interest on convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Non cash interest expense on beneficial conversion feature of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Prepaid expenses
37	-49	-123	224	-32	-38	-92	93	47	2	-27	-2	11	-11	-95	208	-57	-50	-94	73	176	-48	-684	532	1	206	56	-259	363	124	18	-27	0	-10	25	-9	38	-14
Other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-150	-	0	0	0	0	0	0	0	0	0	0	0	-167	-42	0	0
Deferred expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-125	-250	0	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Other assets
-3	-3	23	0	-1	-1	-8	-13	-14	-14	-2	-14	-14	-8	-	-	-	-	142	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses- related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	-13	-19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
15	346	63	22	-96	96	27	119	-14	-45	23	-13	-143	172	24	-104	117	-30	66	-478	345	-220	121	10	-163	144	25	-48	-98	146	29	-20	131	18	-246	-10	151	56
Accounts payable - related party
272	-109	93	-70	82	610	-1,581	214	656	478	340	-32	-625	-109	386	-730	372	422	382	-274	301	-142	-	-	-253	429	-	-36	225	75	-19	-351	25	247	23	-305	86	-534
Accrued expenses
-8	-7	-38	-31	-92	-21	-153	381	-8	0	-18	0	15	0	-42	65	-6	-8	-96	-36	-103	173	-115	-17	-94	115	57	75	-26	1	45	2	-45	66	55	-168	40	13
Deferred interest payable
-	-	-	-	-	-	0	0	0	-41	-41	-41	-41	-41	-41	-41	-41	-41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET CASH USED IN OPERATING ACTIVITIES
-	-	-1,669	-2,010	-2,158	-962	-3,519	-1,295	-1,403	-1,556	-1,009	-2,052	-2,611	-2,224	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,345	-	-1,418	-1,226	-676	-841	-1,218	-999	-1,448
Accrued payroll to officers and related payroll tax expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
NET CASH USED IN OPERATING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,580	-1,212	-1,653	-1,255	-2,088	-1,172	-1,696	-955	-1,860	-2,193	-1,324	-	-	-	-	-	-	-	-	-	-	-	-
CASH FLOWS FROM INVESTING ACTIVITIES:
Collateral advance for affiliate
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,000	0	1,000	0	0	-	-	-	-	-	-	-	-
Purchase of property and equipment
0	4	9	6	20	37	16	132	62	30	46	94	0	24	52	60	29	333	1,195	250	4,750	562	1,612	1,260	83	2,273	64	0	0	0	0	0	0	23	21	24	0	106
NET CASH USED IN INVESTING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-11	-18	-29	-23	-37	-8	-124
CASH FLOWS FROM FINANCING ACTIVITIES
Deferred issuance costs
141	242	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of trademark
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	11	18	5	1	21	0	17
NET CASH USED IN INVESTING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-612	-1,260	-83	-3,273	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	6,000	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of Convertible Preferred Series C stock, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,300	2,295
Proceeds from issuance of common stock and warrants in connection with private placements of common stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	18,912	0	9,690	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	60	6,682	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	185	-	0	0	0	-	0	0	0	-	-	-	-
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Collection of stock subscriptions received
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
NET CASH PROVIDED BY FINANCING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,000	19,437	25	9,876	-	-	-	-	-	-	-	-	-	-	-	-
NET CASH PROVIDED BY FINANCING ACTIVITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	2,315	2,464	2,360	2,325	25	2,325	2,295
NET CHANGE IN CASH AND CASH EQUIVALENTS
-167	-1,680	-1,681	333	-2,178	-999	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
NET CHANGE IN CASH AND CASH EQUIVALENTS
-	-	-	-	-	-	-	-	-	-1,587	-	-3,146	-2,611	-2,249	-1,434	-2,641	-1,242	-1,987	-2,451	-1,339	-5,862	4,423	3,431	16,316	-2,252	5,277	-1,534	1,577	950	-1,345	1,290	885	1,219	1,655	1,460	-1,231	1,317	721
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid
0	0	0	0	0	0	0	0	0	166	-318	165	40	286	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	301	203	286	980	0	-245	245	480	0	0	0	197	0	0	0	0	0	0	0	0	0	0	0
Income tax paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-cash Financing and Investing Activities:
Common stock issued for debenture payment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-494	1,646	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock warrants granted to scientific advisory board
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	106	-	31	24	50	-	-	-	-	-	-	-	-
Stock warrants granted to brokers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	113	-	0	0	0	-	-	-	-	-	-	-	-
Debt discount related to beneficial conversion feature of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Stock Warrants issued in connection with Private Placement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued for accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Common stock issued for equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-